Gemcitabine Combination Nano Therapies for Pancreatic Cancer
Sign Up to like & getrecommendations! Published in 2019 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics11110574
Abstract: Pancreatic cancer is one of the deadliest causes of cancer-related death in the United States, with a 5-year overall survival rate of 6 to 8%. These statistics suggest that immediate medical attention is needed. Gemcitabine… read more here.
Keywords: delivery; gemcitabine combination; pancreatic cancer; cancer ... See more keywords